Gabriele Escherich

Prof. Dr. Gabriele Escherich is a Professor in the Department of Pediatric Hematology and Oncology at the University Medical Center Hamburg-Eppendorf (UKE). She leads the COALL-Study and holds clinical roles in the Ambulatory and Day Clinic. Her research focuses on pediatric leukemia, treatment outcomes, and psychosocial aspects of survivorship. She is involved in international clinical trials (e.g., Interfant-06, EsPhALL2010) and has published extensively on genetic, immunological, and pharmacological aspects of pediatric cancers.

Research interests include minimal residual disease (MRD) monitoring, targeted therapies (e.g., imatinib, blinatumomab), and long-term survivorship care. She collaborates globally on studies addressing steroid toxicity, neurotoxicity, and genetic biomarkers in leukemia. Her work emphasizes translational research and improving clinical protocols for high-risk pediatric cancers.

Key contributions include the validation of prognostic indices for acute lymphoblastic leukemia (ALL) and advancements in understanding BCR-ABL1-like and KMT2A-rearranged leukemias. She leads initiatives like the AELKI study to enhance long-term care for survivors.